INMED PHARMACEUTICALS INC (INM) Stock Analyst Ratings
USA - NASDAQ:INM - CA4576377002 - Common Stock
1.6385 USD
+0.04 (+2.41%)
ChartMill assigns a Buy % Consensus number of 45% to INM. The Buy consensus is the weighted average rating of the current analysts ratings.
INM was analyzed by 8 analysts. The buy percentage consensus is at 45. So analysts seem to be rather negative about INM.
In the previous month the buy percentage consensus was at a similar level.
INM was analyzed by 8 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-11-29 | HC Wainwright & Co. | Initiate | Buy |
| 2021-02-16 | Roth Capital | Maintains | Buy |
INMED PHARMACEUTICALS INC / INM FAQ
What is the consensus rating for INM stock?
The consensus rating for INMED PHARMACEUTICALS INC (INM) is 45 / 100 . This indicates that analysts generally have a neutral outlook on the stock.